JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Scope & Guideline

Connecting scholars to cutting-edge thrombolysis studies.

Introduction

Explore the comprehensive scope of JOURNAL OF THROMBOSIS AND THROMBOLYSIS through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore JOURNAL OF THROMBOSIS AND THROMBOLYSIS in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN0929-5305
PublisherSPRINGER
Support Open AccessNo
CountryNetherlands
TypeJournal
Convergefrom 1994 to 2024
AbbreviationJ THROMB THROMBOLYS / J. Thromb. Thrombolysis
Frequency8 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressVAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS

Aims and Scopes

The Journal of Thrombosis and Thrombolysis aims to advance the understanding of thrombotic and thrombolytic processes, focusing on the mechanisms, diagnosis, treatment, and prevention of thromboembolic diseases. It encompasses a wide range of topics related to coagulation, anticoagulation therapies, and the impact of various conditions on thrombotic events.
  1. Thromboembolic Disease Research:
    The journal emphasizes research on various forms of thromboembolic diseases, including venous thromboembolism (VTE), pulmonary embolism, and arterial thrombosis, investigating their epidemiology, risk factors, and clinical outcomes.
  2. Anticoagulation Therapy:
    It publishes studies on the efficacy and safety of anticoagulation therapies, including direct oral anticoagulants (DOACs), vitamin K antagonists, and novel anticoagulants, focusing on their use in different patient populations.
  3. Mechanisms of Coagulation and Thrombosis:
    Research exploring the underlying biological mechanisms of coagulation, the role of platelets, and the genetic factors influencing thrombotic events is a core focus, contributing to the understanding of thrombosis at a molecular level.
  4. Clinical Guidelines and Practice:
    The journal provides a platform for the dissemination of clinical guidelines and best practices in the management of thromboembolic diseases, integrating evidence-based medicine into clinical practice.
  5. Innovative Diagnostic Approaches:
    It highlights advancements in diagnostic methodologies for thromboembolic diseases, including imaging techniques and biomarkers, facilitating early detection and management.
Recent years have seen the emergence of several key themes within the Journal of Thrombosis and Thrombolysis, reflecting the evolving landscape in thrombosis research and clinical practice.
  1. COVID-19 Related Thrombosis:
    A significant increase in studies addressing thrombotic complications associated with COVID-19 has emerged, highlighting the pandemic's impact on thromboembolic disease research and management.
  2. Machine Learning and Predictive Analytics:
    There is a growing trend towards utilizing machine learning and predictive analytics in identifying thrombosis risk factors and outcomes, representing a shift towards data-driven approaches in clinical research.
  3. Personalized Anticoagulation Strategies:
    Emerging research focuses on individualized anticoagulation therapy, considering genetic, demographic, and clinical variables to optimize treatment outcomes for patients.
  4. Cancer-Associated Thrombosis:
    An increasing number of studies are dedicated to understanding the mechanisms and management of thrombosis in cancer patients, reflecting the critical interplay between malignancy and thromboembolic risk.
  5. Longitudinal Studies and Real-World Evidence:
    There is a trend towards conducting longitudinal and real-world studies to assess the long-term outcomes of various thromboembolic treatments, emphasizing the importance of practical evidence in clinical decision-making.

Declining or Waning

While the journal continues to cover a wide array of topics, some previously prominent areas of focus appear to be declining in frequency or interest, reflecting changes in the clinical landscape and research priorities.
  1. Traditional Antithrombotic Therapies:
    Research on older antithrombotic agents like unfractionated heparin and warfarin is becoming less common as newer therapies gain prominence, leading to a shift in focus towards novel anticoagulants and their comparative effectiveness.
  2. Generalized Risk Factors for Thrombosis:
    While risk factors for thrombosis were once a major focus, there is a noticeable decline in studies addressing generalized risk factors, as researchers are now more focused on specific patient populations and their unique risk profiles.
  3. Non-Pharmacological Interventions:
    Research on non-pharmacological interventions for thrombosis prevention, such as lifestyle modifications or physical therapies, is less frequently published, likely overshadowed by pharmacological advancements.
  4. Thrombolysis Techniques:
    The frequency of studies on traditional thrombolytic techniques appears to be waning, as interest shifts towards more innovative approaches and technologies in thrombectomy and catheter-directed therapies.

Similar Journals

BMC Pulmonary Medicine

Empowering innovation in pulmonary medicine for a healthier tomorrow.
Publisher: BMCISSN: 1471-2466Frequency: 1 issue/year

BMC Pulmonary Medicine is a leading open access journal dedicated to the field of pulmonary and respiratory medicine, published by BMC since its inception in 2001. With an ISSN of 1471-2466, this journal plays a pivotal role in advancing knowledge and research dissemination in its field, maintaining a prominent position with a 2023 Scopus ranking of #65 out of 155 journals, placing it within the 58th percentile of the category. Based in the United Kingdom, it operates under a collaborative mission to provide unrestricted access to vital research, contributing to the global understanding of respiratory health issues. The journal is recognized for its commitment to high-quality, peer-reviewed research, as evidenced by its Q2 category designation in Pulmonary and Respiratory Medicine. BMC Pulmonary Medicine aims to foster innovation and scholarship among researchers, professionals, and students, making it an indispensable resource for anyone engaged in pulmonary research and practice. The journal, accessible to everyone, enables the dissemination of impactful research that can influence clinical practice and policy worldwide.

Journal of Stroke

Connecting Researchers and Clinicians for Stroke Progress
Publisher: KOREAN STROKE SOCISSN: 2287-6391Frequency: 3 issues/year

Journal of Stroke is a premier open-access journal published by the Korean Stroke Society, dedicated to advancing the understanding of stroke through cutting-edge research and innovative clinical practices. Since its inception in 2013, the journal has gained notable recognition in the fields of Cardiology and Cardiovascular Medicine and Neurology, reflecting its commitment to high-quality, peer-reviewed content, with rankings in the top quartiles (Q1) for both categories as of 2023. The journal’s impact is underscored by its Scopus rankings, placing it in the 92nd and 91st percentiles within its respective fields, thus serving as a vital resource for researchers, clinicians, and students seeking to enhance their knowledge and contribute to stroke research and treatment methodologies. The Journal of Stroke is strategically positioned in South Korea and fosters a global dialogue on stroke-related issues, reinforcing its role as a pivotal platform for disseminating vital findings that can influence both clinical practices and health policy.

International Journal of Stroke

Bridging Research and Practice in Stroke Healthcare
Publisher: SAGE PUBLICATIONS LTDISSN: 1747-4930Frequency: 9 issues/year

The International Journal of Stroke, published by SAGE PUBLICATIONS LTD, is a leading peer-reviewed journal dedicated to advancing the field of stroke research and clinical practice. Established with a commitment to disseminating high-quality scholarly articles, this journal has rapidly progressed to achieve a prestigious Q1 ranking in both Neurology and Clinical Neurology categories as of 2023. With a remarkably high Scopus rank of #7 among 192 in Neuroscience and #16 among 400 in Clinical Neurology, it places itself firmly in the top 4% of journals in its field, reflecting its significant impact on the academic and clinical landscape. Although it does not currently offer Open Access options, the journal provides a vital platform for researchers and clinicians alike, focusing on innovative treatments, methodologies, and evolving strategies for stroke prevention and recovery. With a publication scope that spans from 2006 to 2024, the International Journal of Stroke continues to foster knowledge exchange and encourage collaboration, making it an essential resource for anyone involved in neurologic healthcare.

NEUROLOGIST

Innovating Understanding in Neurological Disorders
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1074-7931Frequency: 6 issues/year

NEUROLOGIST, an esteemed journal published by Lippincott Williams & Wilkins, serves as a vital resource in the fields of Neurology and Medicine. With an ISSN of 1074-7931 and an E-ISSN of 2331-2637, this journal has been dedicated to advancing the understanding of neurological disorders since its inception in 1996, with continual contributions through 2024. Achieving a respectable Q3 rank in both Medicine (miscellaneous) and Neurology (clinical), it provides an essential platform for disseminating innovative research and clinical studies. Although it is not an open-access publication, NEUROLOGIST promotes a rich exchange of ideas and findings for researchers, healthcare professionals, and students alike, helping to bridge the gaps in neurological research and practice. The journal is recognized for its commitment to enhancing clinical practice and research methodology, making it a valuable asset for anyone engaged in the dynamic field of neurology.

Journal of Vascular Surgery-Venous and Lymphatic Disorders

Connecting global expertise in vascular surgery.
Publisher: ELSEVIERISSN: 2213-333XFrequency: 6 issues/year

The Journal of Vascular Surgery-Venous and Lymphatic Disorders, published by Elsevier, is a distinguished peer-reviewed journal dedicated to advancing the knowledge and practice of vascular surgery with a particular focus on venous and lymphatic conditions. With an ISSN of 2213-333X and a robust impact factor, this journal ranks Q2 in Cardiology and Cardiovascular Medicine and Q1 in Surgery, reflecting its high relevance and contribution to the field. Covering a wide spectrum of topics from innovative surgical techniques to the latest developments in venous and lymphatic disorders, the journal serves as a vital resource for researchers, clinicians, and students alike. It not only disseminates cutting-edge research but also promotes best practices and interdisciplinary collaboration within the cardiovascular domain. The journal is accessible to a global audience, ensuring that impactful findings reach practitioners and researchers everywhere, further elevating the standards of patient care and surgical excellence.

Hamostaseologie

Advancing Hematology: Unraveling the Complexities of Hemostasis
Publisher: GEORG THIEME VERLAG KGISSN: 0720-9355Frequency: 4 issues/year

Hamostaseologie is a prominent academic journal dedicated to the field of hematology, published by GEORG THIEME VERLAG KG. With an ISSN of 0720-9355 and an E-ISSN of 2567-5761, this journal has been at the forefront of critical research and advancements since its inception in 1981, and it continues to maintain its relevance in the scientific community with a converged publication until 2024. Ranked in the Q3 quartile in Hematology for 2023, and positioned at #44 out of 137 in the Scopus Medicine Hematology category, it represents a substantial contribution to scholarly discourse. Researchers and professionals alike will find valuable insights within its pages, as it disseminates rigorous studies and reviews that address pertinent issues related to hemostasis and coagulation. While the journal does not currently offer Open Access, readers can access its valuable content through institutional subscriptions, making it an essential resource for students, clinicians, and researchers aiming to deepen their understanding of hematological science.

Lung India

Advancing respiratory health through accessible research.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0970-2113Frequency: 6 issues/year

Lung India is a premier open-access journal dedicated to the dissemination of high-quality research in the field of Pulmonary and Respiratory Medicine. Published by Wolters Kluwer Medknow Publications, it has been forging a path in respiratory healthcare since its inception in 2004. With its impactful contributions to clinical practice and research, Lung India holds a solid position in the academic landscape, evidenced by its ranking in the Q3 quartile for Pulmonary and Respiratory Medicine as of 2023, and its Scopus rank of #99 out of 155. The journal is particularly important for researchers, clinicians, and students in India and beyond, providing a platform for the latest findings and developments in respiratory care, lung disease management, and innovative treatment methods. With a commitment to accessibility, Lung India aims to promote knowledge sharing among professionals and support the advancement of respiratory health. The journal is well-equipped to cater to a diverse audience, ensuring that vital research is readily accessible and impactful.

Hematology-American Society of Hematology Education Program

Advancing Hematology through Expert Education
Publisher: AMER SOC HEMATOLOGYISSN: 1520-4391Frequency: 1 issue/year

Hematology-American Society of Hematology Education Program is a premier peer-reviewed journal dedicated to advancing the field of hematology through comprehensive educational content. Published by the American Society of Hematology, this journal plays a crucial role in disseminating knowledge to researchers, clinicians, and students in hematology and related disciplines. With an impressive Q1 status in the field, it ranks among the top journals at the forefront of hematological research, as evidenced by its 60th percentile ranking in Scopus' Medicine - Hematology category. Although it does not offer open access, the journal provides invaluable insights and educational resources from leading experts, focusing on the latest advancements, treatment protocols, and evolving understanding of blood disorders. Covering a wide range of topics, from basic research to clinical applications, this journal is essential for anyone seeking to deepen their expertise and stay informed on the latest developments in hematology. For further engagement, readers can access insightful articles published since 2001, ensuring a rich repository of knowledge for ongoing research and clinical excellence.

Research and Practice in Thrombosis and Haemostasis

Empowering research for better patient outcomes.
Publisher: ELSEVIERISSN: Frequency: 8 issues/year

Research and Practice in Thrombosis and Haemostasis, published by Elsevier, is a prominent open-access journal dedicated to advancing the field of hematology through high-quality research and clinical practice. Since its inception in 2017, this journal has established itself as a vital resource for researchers, healthcare professionals, and students interested in thrombosis and hemorrhage management, showcasing original research, reviews, and clinical studies. The journal’s commitment to accessible knowledge is reflected in its open-access model, allowing researchers worldwide to share their findings without financial barriers. With an impressive 2023 Scopus rank of #42 out of 137 in the hematology category and a respectable Q2 classification, it provides an authoritative platform for innovative ideas and cutting-edge developments in the field. As the journal continues to grow in stature, it aims to foster collaboration and knowledge exchange amongst professionals dedicated to improving patient outcomes in thrombosis and hemostasis.

International Journal of Angiology

Exploring innovative insights in angiology and cardiology.
Publisher: THIEME MEDICAL PUBL INCISSN: 1061-1711Frequency: 4 issues/year

Welcome to the International Journal of Angiology, a distinguished publication dedicated to advancing the field of cardiology and cardiovascular medicine. Published by THIEME MEDICAL PUBL INC, this journal plays a crucial role in disseminating innovative research and clinical insights from 1992 through 2024, serving as a vital resource for researchers, healthcare professionals, and students alike. With an ISSN of 1061-1711 and an E-ISSN of 1615-5939, the journal currently holds a respectable Q4 ranking in the cardiology field, reflecting its commitment to quality and relevance. Although it operates under a traditional access model, the journal ensures that critical research findings are shared with a broad audience, fostering collaboration and knowledge exchange. By exploring current trends, diagnostic techniques, and treatment modalities in angiology, the International Journal of Angiology remains an essential platform for those dedicated to improving cardiovascular health around the globe.